Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:MEDP On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeMEDPMedpace$310.69+1.3%$300.94$250.05▼$459.77$8.93B1.47372,612 shs677,983 shs13 Stocks Institutional Investors Won't Stop BuyingWhich stocks are hedge funds and endowments buying in today's market? Enter your email address and we'll send you MarketBeat's list of thirteen stocks that institutional investors are buying now.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceMEDPMedpace0.00%+0.43%+4.80%+1.97%-24.56%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationMEDPMedpace4.7826 of 5 stars3.12.00.04.62.74.22.5Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceMEDPMedpace 2.21Hold$344.8210.98% UpsideCurrent Analyst Ratings BreakdownLatest MEDP Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails6/24/2025MEDPMedpaceBarclaysSubscribe to MarketBeat All Access for the recommendation accuracy ratingInitiated CoverageOutperform ➝ Equal Weight$300.004/23/2025MEDPMedpaceTruist FinancialSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetHold ➝ Hold$333.00 ➝ $300.004/23/2025MEDPMedpaceRobert W. BairdSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetNeutral ➝ Neutral$340.00 ➝ $313.004/22/2025MEDPMedpaceWilliam BlairSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingOutperform ➝ Market Perform4/14/2025MEDPMedpaceTD CowenSubscribe to MarketBeat All Access for the recommendation accuracy ratingDowngradeBuy ➝ Hold$370.00 ➝ $328.004/10/2025MEDPMedpaceTruist FinancialSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetHold ➝ Hold$347.00 ➝ $333.004/9/2025MEDPMedpaceMizuhoSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetOutperform ➝ Outperform$400.00 ➝ $355.00(Data available from 6/30/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookMEDPMedpace$2.11B4.23$13.95 per share22.27$26.56 per share11.70Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateMEDPMedpace$404.39M$13.1023.7222.745.6119.31%54.36%20.81%7/21/2025 (Confirmed)Latest MEDP EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails7/21/2025Q2 2025MEDPMedpace$3.01N/AN/AN/A$537.70 millionN/A4/21/2025Q1 2025MEDPMedpace$3.06$3.67+$0.61$3.67$528.38 million$558.57 millionCompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthMEDPMedpaceN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioMEDPMedpaceN/A0.730.73Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipMEDPMedpace77.98%Insider OwnershipCompanyInsider OwnershipMEDPMedpace20.30%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableMEDPMedpace5,90028.74 million22.91 millionOptionableMEDP HeadlinesRecent News About These CompaniesWealth Enhancement Advisory Services LLC Has $2.22 Million Stock Position in Medpace Holdings, Inc. (NASDAQ:MEDP)June 29 at 3:04 AM | marketbeat.comMedpace Holdings, Inc. (MEDP) Cash Flow - Yahoo FinanceJune 27 at 12:02 AM | finance.yahoo.comMEDP - Medpace Holdings Inc Valuation | MorningstarJune 27 at 12:02 AM | morningstar.comMMedpace (MEDP) Stock Dips While Market Gains: Key FactsJune 26, 2025 | zacks.comMoran Wealth Management LLC Purchases Shares of 16,928 Medpace Holdings, Inc. (NASDAQ:MEDP)June 26, 2025 | marketbeat.comMedpace (NASDAQ:MEDP) Coverage Initiated at BarclaysJune 26, 2025 | americanbankingnews.comReflecting On Drug Development Inputs & Services Stocks’ Q1 Earnings: Medpace (NASDAQ:MEDP)June 25, 2025 | msn.comBessemer Group Inc. Purchases 6,225 Shares of Medpace Holdings, Inc. (NASDAQ:MEDP)June 25, 2025 | marketbeat.comBarclays Initiates Coverage of Medpace Holdings (MEDP) with Equal-Weight RecommendationJune 25, 2025 | msn.comMedpace Holdings, Inc. to Report Second Quarter 2025 Financial Results on July 21, 2025 - Business WireJune 24, 2025 | businesswire.comMEDP - Medpace Holdings Inc Trailing Returns | MorningstarJune 24, 2025 | morningstar.comMBarclays Begins Coverage on Medpace (NASDAQ:MEDP)June 24, 2025 | marketbeat.comInvesco LLC Sells 1,343 Shares of Medpace Holdings, Inc. (NASDAQ:MEDP)June 24, 2025 | marketbeat.comOppenheimer Asset Management Inc. Sells 1,110 Shares of Medpace Holdings, Inc. (NASDAQ:MEDP)June 24, 2025 | marketbeat.comMedpace Holdings, Inc. to Report Second Quarter 2025 Financial Results on July 21, 2025June 23, 2025 | businesswire.com1,972 Shares in Medpace Holdings, Inc. (NASDAQ:MEDP) Acquired by Ausbil Investment Management LtdJune 23, 2025 | marketbeat.comCabot Wealth Management Inc. Acquires 1,473 Shares of Medpace Holdings, Inc. (NASDAQ:MEDP)June 21, 2025 | marketbeat.comRiverbridge Partners LLC Has $146.59 Million Holdings in Medpace Holdings, Inc. (NASDAQ:MEDP)June 20, 2025 | marketbeat.comMedpace Holdings, Inc. (NASDAQ:MEDP) Shares Purchased by QRG Capital Management Inc.June 19, 2025 | marketbeat.comJanney Montgomery Scott LLC Has $15.41 Million Stock Position in Medpace Holdings, Inc. (NASDAQ:MEDP)June 19, 2025 | marketbeat.comSG Americas Securities LLC Trims Stock Position in Medpace Holdings, Inc. (NASDAQ:MEDP)June 18, 2025 | marketbeat.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeMEDP Company DescriptionsMedpace NASDAQ:MEDP$310.69 +3.89 (+1.27%) Closing price 06/27/2025 04:00 PM EasternExtended Trading$309.77 -0.92 (-0.29%) As of 06/27/2025 07:59 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Medpace Holdings, Inc. engages in the provision of outsourced clinical development services to the biotechnology, pharmaceutical and medical device industries. Its services include medical department, clinical trial management, data-driven feasibility, study-start-up, clinical monitoring, regulatory affairs, patient recruitment and retention, medical writing, biometrics and data sciences, pharmacovigilance, core laboratory, laboratories, clinics, and quality assurance. The company was founded by August James Troendle in 1992 and is headquartered in Cincinnati, OH. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30EcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas Nike Stock: The Mother of All Comebacks Might Have Just Begun EA Just Caught a Monster Upgrade: Bullish Breakout Ahead? Snowflake Hits 52-Week High—Options Traders Bet on Further Rally Addition by Subtraction: Intel’s New Strategy Energizes Investors Apple: The Mag 7’s Dead Money Stock or AI Cash Cow in the Making? NVIDIA’s Stock Price Hits New Highs: This Is What’s Next Micron: A Hot Buy Heats Up, Fresh All-Time Highs Are Coming Rocket Lab: Europe Comes Calling as Momentum Builds Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
